Faster Genomics-Based Diagnosis May Accelerate Treatment of Myeloid Neoplasms Patients
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Leukemia |
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read MorePosted by Andy Lundin | Jan 25, 2023 | Company News, Leukemia |
Alercell has launched a new website—Lena Diagnostics—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Read MorePosted by Andy Lundin | Jan 17, 2023 | Molecular Diagnostics |
Optical genome mapping can outperform standard tests used for common blood cancers and help make better, more specific, diagnosis.
Read MorePosted by Andy Lundin | Dec 30, 2022 | Leukemia |
Alercell is launching a leukemia diagnostic test based on sequencing DNA that will detect up to 51 Genes mutations in Leukemia patients.
Read MorePosted by Andy Lundin | Dec 13, 2022 | Cancer |
A new clinical tool pinpoints which clonal hematopoiesis patients are at highest risk for cancer progression.
Read More